Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats

Fig. 5

Peri-SCN area dopaminergic neuron lesion increased plasma leptin (a), plasma insulin (b) and plasma norepinephrine (c). Animals received an infusion of 6-OHDA (2–4 μg/side) at the peri-SCN area bilaterally, data were collected 17 weeks post-lesion. Data are represented as the mean ± SEM. * Significant difference between treatment groups (P < 0.05, unpaired Student’s t-test). †P < 0.05, 1-tailed t test

Back to article page